Literature DB >> 21194624

DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.

Virtudes Moreno1, Mercè Font-Bardia, Teresa Calvet, Julia Lorenzo, Francesc X Avilés, M Helena Garcia, Tânia S Morais, Andreia Valente, M Paula Robalo.   

Abstract

Four ruthenium(II) complexes with the formula [Ru(η(5)-C(5)H(5))(PP)L][CF(3)SO(3)], being (PP = two triphenylphosphine molecules), L = 1-benzylimidazole, ; (PP = two triphenylphosphine molecules), L = 2,2'bipyridine, ; (PP = two triphenylphosphine molecules), L = 4-Methylpyridine, ; (PP = 1,2-bis(diphenylphosphine)ethane), L = 4-Methylpyridine, , were prepared, in view to evaluate their potentialities as antitumor agents. The compounds were completely characterized by NMR spectroscopy and their crystal and molecular structures were determined by X-ray diffraction. Electrochemical studies were carried out giving for all the compounds quasi-reversible processes. The images obtained by atomic force microscopy (AFM) suggest interaction with pBR322 plasmid DNA. Measurements of the viscosity of solutions of free DNA and DNA incubated with different concentrations of the compounds confirmed this interaction. The cytotoxicity of compounds 1234 was much higher than that of cisplatin against human leukemia cancer cells (HL-60 cells). IC(50) values for all the compounds are in the range of submicromolar amounts. Apoptotic death percentage was also studied resulting similar than that of cisplatin. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194624     DOI: 10.1016/j.jinorgbio.2010.10.009

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  8 in total

1.  Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes.

Authors:  Leonor Côrte-Real; Filipa Mendes; Joana Coimbra; Tânia S Morais; Ana Isabel Tomaz; Andreia Valente; M Helena Garcia; Isabel Santos; Manuel Bicho; Fernanda Marques
Journal:  J Biol Inorg Chem       Date:  2014-02-23       Impact factor: 3.358

2.  Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.

Authors:  Golara Golbaghi; Irène Pitard; Matthieu Lucas; Mohammad Mehdi Haghdoost; Yossef López de Los Santos; Nicolas Doucet; Shunmoogum A Patten; J Thomas Sanderson; Annie Castonguay
Journal:  Eur J Med Chem       Date:  2020-01-03       Impact factor: 6.514

3.  Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cells.

Authors:  Aliny Pereira Lima; Flávia Castro Pereira; Marcio Aurelio Pinheiro Almeida; Francyelli Mariana Santos Mello; Wanessa Carvalho Pires; Thallita Monteiro Pinto; Flávia Karina Delella; Sérgio Luis Felisbino; Virtudes Moreno; Alzir Azevedo Batista; Elisângela de Paula Silveira-Lacerda
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

4.  Mirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.

Authors:  Ying Fu; Rina Soni; María J Romero; Ana M Pizarro; Luca Salassa; Guy J Clarkson; Jessica M Hearn; Abraha Habtemariam; Martin Wills; Peter J Sadler
Journal:  Chemistry       Date:  2013-09-23       Impact factor: 5.236

Review 5.  Metal complexes in cancer therapy - an update from drug design perspective.

Authors:  Umar Ndagi; Ndumiso Mhlongo; Mahmoud E Soliman
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162

6.  Ultrasonication Improves Solid Phase Synthesis of Peptides Specific for Fibroblast Growth Factor Receptor and for the Protein-Protein Interface RANK-TRAF6.

Authors:  Rúben D M Silva; João Franco Machado; Kyle Gonçalves; Francisco M Lucas; Salete Batista; Rita Melo; Tânia S Morais; João D G Correia
Journal:  Molecules       Date:  2021-12-03       Impact factor: 4.411

7.  Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model.

Authors:  Leonor Côrte-Real; Ana Rita Brás; Adhan Pilon; Nuno Mendes; Ana Sofia Ribeiro; Tiago D Martins; José Paulo S Farinha; M Conceição Oliveira; Fátima Gärtner; M Helena Garcia; Ana Preto; Andreia Valente
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

8.  Binding of RuCp complexes with human apo-transferrin: fluorescence spectroscopy and molecular docking methods.

Authors:  Filipa C Santos; Paulo J Costa; M Helena Garcia; Tânia S Morais
Journal:  Biometals       Date:  2021-06-22       Impact factor: 2.949

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.